Oculis appoints Sharon Klier as CDO

Oculis Holding announced the appointment of Dr. Sharon Klier to the role of Chief Development Officer. In this key role, Dr. Klier will oversee and provide strategic leadership across the clinical development and operations of Oculis’ robust ophthalmology pipeline. Before joining Oculis, she served as Chief Development Officer, Head of Ophthalmology at UNITY Biotechnology, where she played a key role in driving forward UNITY’s pipeline.